» Articles » PMID: 20587179

Ebola Hemorrhagic Fever Associated with Novel Virus Strain, Uganda, 2007-2008

Abstract

During August 2007-February 2008, the novel Bundibugyo ebolavirus species was identified during an outbreak of Ebola viral hemorrhagic fever in Bundibugyo district, western Uganda. To characterize the outbreak as a requisite for determining response, we instituted a case-series investigation. We identified 192 suspected cases, of which 42 (22%) were laboratory positive for the novel species; 74 (38%) were probable, and 77 (40%) were negative. Laboratory confirmation lagged behind outbreak verification by 3 months. Bundibugyo ebolavirus was less fatal (case-fatality rate 34%) than Ebola viruses that had caused previous outbreaks in the region, and most transmission was associated with handling of dead persons without appropriate protection (adjusted odds ratio 3.83, 95% confidence interval 1.78-8.23). Our study highlights the need for maintaining a high index of suspicion for viral hemorrhagic fevers among healthcare workers, building local capacity for laboratory confirmation of viral hemorrhagic fevers, and institutionalizing standard precautions.

Citing Articles

Implementation of an infection prevention and control response strategy to combat the Sudan Virus Disease outbreak in an urban setting, the Kampala Metropolitan area, Uganda, 2022.

Nanyondo S, Nakato S, Franklin J, Kwiringira A, Malikisi M, Kesande M BMC Infect Dis. 2025; 25(1):317.

PMID: 40050780 PMC: 11883975. DOI: 10.1186/s12879-025-10720-0.


The Development of Ebola Virus Outbreaks: A Review of Epidemiological Trends, Clinical Features, and Treatment Advances.

Mohd O, Sawaqed S, Kundu M, Ghannam R, Mohd A, AlSamhori J Cureus. 2024; 16(11):e74078.

PMID: 39712786 PMC: 11660724. DOI: 10.7759/cureus.74078.


Ebola disease outbreak caused by the Sudan virus in Uganda, 2022: a descriptive epidemiological study.

Kabami Z, Ario A, Harris J, Ninsiima M, Ahirirwe S, Ocero J Lancet Glob Health. 2024; 12(10):e1684-e1692.

PMID: 39222652 PMC: 11413514. DOI: 10.1016/S2214-109X(24)00260-2.


Non-Ebola Filoviruses: Potential Threats to Global Health Security.

Munyeku-Bazitama Y, Edidi-Atani F, Takada A Viruses. 2024; 16(8).

PMID: 39205153 PMC: 11359311. DOI: 10.3390/v16081179.


An update on nonhuman primate usage for drug and vaccine evaluation against filoviruses.

de La Vega M, Xiii A, Massey S, Spengler J, Kobinger G, Woolsey C Expert Opin Drug Discov. 2024; 19(10):1185-1211.

PMID: 39090822 PMC: 11466704. DOI: 10.1080/17460441.2024.2386100.


References
1.
Francesconi P, Yoti Z, Declich S, Onek P, Fabiani M, Olango J . Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis. 2004; 9(11):1430-7. PMC: 3035551. DOI: 10.3201/eid0911.030339. View

2.
. Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001. MMWR Morb Mortal Wkly Rep. 2001; 50(5):73-7. View

3.
. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ. 1978; 56(2):247-70. PMC: 2395561. View

4.
. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 1978; 56(2):271-93. PMC: 2395567. View

5.
Towner J, Sealy T, Khristova M, Albarino C, Conlan S, Reeder S . Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008; 4(11):e1000212. PMC: 2581435. DOI: 10.1371/journal.ppat.1000212. View